Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/27/26 17:50 | 3/25/26 | KALV | Health | Drug | Pharmaceutical Preparations | Venrock Healthcare Capital Partners Iii, L.P. | NY | T | 1 | S.m | -3,691 | 17.20 | 0 | -215 | 5,089 | I | ||||||||||||||||
3/10/26 18:47 | 9/8/25 | KALV | Health | Drug | Pharmaceutical Preparations | Palleiko Benjamin L | MA | DO | CEO | 18 | S.d | -2,011 | 14.05 | 0 | -143 | 452 | D | |||||||||||||||
2/24/26 19:44 | 2/23/26 | KALV | Health | Drug | Pharmaceutical Preparations | Audhya Paul K. | MA | O | CHIEF ME | 12 | S.d | -469 | 12.95 | 0 | -36 | 139 | D | |||||||||||||||
2/24/26 19:43 | 2/23/26 | KALV | Health | Drug | Pharmaceutical Preparations | Yea Christopher | MA | O | CHIEF DE | 13 | S.d | -873 | 14.31 | 0 | -61 | 227 | D | |||||||||||||||
2/24/26 19:42 | 2/23/26 | KALV | Health | Drug | Pharmaceutical Preparations | Sweeny Nicole | MA | O | Chief Co | 4 | S.d | -158 | 14.16 | 0 | -11 | 47 | D | |||||||||||||||
2/24/26 19:42 | 2/23/26 | KALV | Health | Drug | Pharmaceutical Preparations | Piekos Brian | MA | O | CFO | 2 | S.d | -88 | 14.05 | 0 | -6 | 14 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |